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                              ABSTRACT 
Background and Objectives: 
                   Uninvestigated dyspepsia is common in surgical out patient 
department. The prevalence of clinically significant upper gastrointestinal findings 
in late onset uninvestigated dyspepsia patients and their predictability based on 
history, is unknown. So a study was undertaken in Rajiv Gandhi Govt General 
Hospitals, Madras Medical College,Chennai to study the endoscopic findings in 
dyspeptic patients and to detect the esophagogastroduodenal carcinoma in early 
stages. 
Materials and methods; 
 After informed consent 200 patients aged more than 40 years presenting 
with uninvestigated, untreated and uncomplicated dyspepsia were enrolled and 
evaluated in the study. Patients aged less than 40 years,  patients on Proton pump 
inhibitors, patients who are known  cases of chronic pancreatitis and liver disease, 
patients on NSAID’s for more than  one month duration,  patients who had 
received Anti-Helicobacter pylori treatment and unwilling or  unfit patients for 
endoscopy were excluded from the study. 
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      All patients underwent upper gastro-intestinal endoscopy to document the 
various findings. Biopsies were taken in every patient from the gastric antrum and 
pathological site. The biopsy specimen was subjected to histo pathological 
examination for confirmation .The findings were documented and analysed. 
 
RESULTS; 
 1. Highest prevalence of late onset dyspepsia in the age group of 41-50years 
2. Most common presenting complaint was epigastric pain and discomfort 
3. Dyspepsia was more common in males (59%) when compared to females 
4. Most common endoscopic finding was gastritis followed by GERD 
5. Malignancy was diagnosed in 6.5% patients with dyspepsia. 
6. Clinically significant endoscopic findings were observed in 82.5% of 
patients with uninvestigated dyspepsia. 
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7. Most patients presented with a complex of three or more dyspeptic 
symptoms and the symptom profile was not predictive of the endoscopic findings. 
However, the high prevalence of gastritis (28%), suggests that most patients 
presenting with uninvestigated dyspepsia can be safely managed initially with acid 
suppressive drugs. 
 
Conclusion: 
Clinically significant endoscopic findings were observed in 82.5% of 
patients with uninvestigated dyspepsia. Most patients presented with a complex of 
three or more dyspeptic symptoms and the symptom profile was not predictive of 
the endoscopic findings. A larger number of inflammatory lesions as a result of 
increased acid production and low incidence of malignancy in the study group. It is 
suggested that the uninvestigated patients with dyspepsia may be initially managed 
medically with acid suppressive therapy . 
Endoscopy may be undertaken in patients with recurrent symptoms or in 
whom drug therapy fails 
Key words: Upper GI endoscopy; dyspepsia; H.pylori; GERD. 
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                                       INTRODUCTION 
                    Dyspepsia (also called uninvestigated dyspepsia) had been defined 
by the Rome working teams as pain or discomfort centred in the upper 
abdomen. Pain in the central portion of the abdomen is a key symptom, pain 
located in other areas or related to defecation is excluded. Discomfort is 
considered to be distinct from pain; however, both often coexist and the 
distinction may in part be culturally driven‟‟. 
                   Discomfort has been defined as a subjective negative feeling that 
may include a variety of symptoms such as fullness in the upper abdomen, early 
satiety, bloating or nause.1,2  
                     The definition of dyspepsia includes patients who have intermittent 
or continuous symptoms and does not specify the duration of symptoms. Thus 
dyspepsia may be of short or long duration, but acute self-limited dyspepsia 
does not usually require investigation and will not be considered further here. 
                     The majority of patients who present with chronic dyspepsia have 
no obvious underlying explanation despite appropriate investigation; these cases 
are currently labelled as having non-ulcer (or functional) dyspepsia, although 
this is likely to be a heterogeneous condition.3 The pathophysiology of 
functional dyspepsia remains relatively poorly defined, but sensory and motor 
disorders of the stomach and duodenum appear to play a central role in at least a 
subset of cases.4 
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AIMS AND OBJECTIVES                                         
 
To study  of  upper GI endoscopy findings in dyspeptic patient 
 
    1)The outcome of Upper GI endoscopy in dyspeptic patients 
 
    2) The  co-relation of alarm symptoms with GI endoscopy finding 
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INCLUSION CRITERIA: 
    1) patient age above 40yrs with dyspeptic symptoms. 
    2) Patient with alarm symptoms.  
    3) Patient with previously diagnosed and treated cases of gastric ulcer, 
duodenal ulcer, complicated peptic ulcer, coming with dyspeptic symptoms. 
 
EXCLUSION CRITERIA: 
   1) Patients who are endoscopy negative but have dyspepsia, may have 
motility disorders.  
   2) Individuals who had an endoscopy indications other than dyspepsia. 
    3) Not willing for endoscopy. 
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                                       REVIEW OF LITERATURE 
                                              ANATOMY 
ESOPHAGUS: 
The esophagus, a soft muscular tube, allows food to pass between the pharynx 
and the stomach. It is about 25-30cm in length. The esophagus is a midline 
structure anterior to the spine and posterior to the trachea. From its origin at the 
cricoid cartilage in the neck opposite the fifth to sixth cervical vertebra, it passes 
into the thorax at the level of the sternal notch and travels caudally within the 
chest in the posterior mediastinum. It terminates in the abdomen at the 
esophagogastric junction opposite the twelfth thoracic vertebra. The esophageal 
hiatus of the diaphragm is at the level of the tenth thoracic vertebra.20 
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Anatomically esophagus is divided into three parts: 
 Cervical 
 Thoracic 
 Abdominal 
Function divides the esophagus according to its differing forms of motility into 
the following three zones According to differing forms of motility (functionally) 
esophagus is divided into three zones: 
 Upper esophageal sphincter (UES) 
 Esophageal body 
 Lower esophageal sphincter (LES). 
 
UPPER ESOPHAGEAL SPHINCTER (UES). 
         The high-pressure zone at the inlet of the esophagus is considered as UES. 
Anatomically it marks the end of a complex configuration of muscles that begin 
in the larynx and posterior pharynx and end in the neck. The pharyngeal 
constrictor muscles are three consecutive muscles that begin at the base of the 
palate and end at the crest of the esophagus. The superior and middle 
pharyngeal constrictor muscles, as well as the oblique, transverse, and posterior 
cricoarytenoid muscles, are immediately proximal to the UES and serve to 
 
 
11 
 
anchor the pharynx and the larynx to structures in the mouth and palate. These 
muscles also aid in deglutition and speech, but are not responsible for the high 
pressures noted in the UES. The inferior pharyngeal constrictor muscle is the 
final bridge between the pharyngeal and esophageal musculature. 
 
ESOPHAGEAL LAYERS: 
            The esophagus is comprised of two proper layers: the mucosa and the 
muscularis propria. It is distinguished from the other layers of the alimentary 
tract by its lack of a serosa. The mucosa is the innermost layer and consists of 
squamous epithelium for most of its course. The distal 1 to 2 cm of esophageal 
mucosa transitions to cardiac mucosa or junctional columnar epithelium at a 
point known as the Z-line. Within the mucosa, there are four distinct layers 
 
1. Epithelium 
2. Basement membrane 
3. Lamina propria, and           
4. Muscularis mucosa.      
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HISTOLOGY: 
 
 
 
 
 
                 
              upper third of the esophagus are striated, whereas the layers of the 
lower two thirds are smooth muscle. The circular muscles are an extension of 
the cricopharyngeus muscle and traverse through the thoracic cavity into the 
abdomen, where they become the middle circular muscles of the lesser 
curvature of the stomach. The collar of Helvetius marks the transition of the 
circular muscles of the esophagus to oblique muscles of the stomach at the 
incisura (cardiac notch). Between the layers of esophageal muscle is a thin 
septum comprising connective tissue, blood vessels and an interconnected 
network of ganglia known as Auerbach's plexus. Enshrouding the inner circular 
layer, the longitudinal muscles of the esophagus begin at the cricoid cartilage 
and extend into the abdomen, where they join the longitudinal musculature of 
  
Fig 2. Histology of esophagus 
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the cardia of the stomach. The esophagus is then wrapped by a layer of 
fibroalveolar adventitia. 
ESOPHAGEAL CONSTRICTIONS: 
       The esophageal silhouette resembles an hourglass. There are three distinct 
areas of narrowing that contribute to its shape. Measuring 14 mm in diameter, 
the cricopharyngeus muscle is the narrowest point of the gastrointestinal tract 
and marks the superior-most portion of the hourglass-shaped esophagus.       
Occurring just below the carina, where the left main-stem bronchus and aorta 
abut the esophagus, the bronchoaortic constriction at the level of the 4th 
thoracic vertebra creates the center narrowing and measures 15 to 17 mm. 
Finally, the diaphragmatic constriction, measuring 16 to 19 mm, marks the 
inferior portion of the hourglass and occurs where the esophagus passes  
through the diaphragm. Between these three distinct areas of anatomic 
constriction are two areas of dilation known as the superior and inferior 
dilations. Within these areas, the esophagus resumes the normal diameter for an 
adult and measures about 2.5 cm. 
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LOWER ESOPHAGEAL SPHINCTER (LES): 
                 The final phase of esophageal bolus transit occurs through the LES. 
Although this is not a true sphincter, there is a distinct high-pressure zone that 
measures 2 to 5 cm in length and generates a resting pressure of 6 to 26 mm Hg. 
The LES is located both in the chest and the abdomen. A minimum total length 
of 2 cm, with at least 1 cm of intra-abdominal length, is required for normal 
LES function. The transition from the intrathoracic to the intra-abdominal 
sphincter is noted on a manometric tracing and known as the respiratory 
inversion point (RIP). At this point, the pressure of the esophagus changes from 
negative to positive with inspiration and positive to negative with expiration. 
               Peristaltic contractions alone do not generate enough force to open up 
the LES. Vagal-mediated relaxation of the LES occurs 1.5 to 2.5 seconds after 
pharyngeal swallowing and lasts 4 to 6 seconds. This flawlessly timed 
relaxation is needed to allow efficient transport of a food bolus out of the 
esophagus and into the stomach. A post-relaxation contraction of the LES 
occurs after the peristaltic wave has passed through the esophagus, allowing the 
LES to return to its baseline pressure, re-establishing a barrier to reflux. 21 
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STOMACH: 
                                  Stomach is the most dilated part of the alimentary tract, 
extending from the cardiac end to the pyloric end. The stomach is sub-divided 
into; 
1. Fundus 
2. Body 
3. Pyloric Antrum 
4. Pyloric Canal 
 
            Fundus is the part which rises above the level of cardiac end of the 
stomach.Body is that portion situated between the fundus and the level of 
incisura angularis in the lesser curvature of the stomach. 
The pyloric part is situated below the body and consists of: 
1. Pyloric antrum 
2. Pyloric canal 
It is in the pyloric antrum where Helicobacter pylori is most frequently 
colonized. 
 
 
 
16 
 
 
 
 
 
 
 
 
                                                         Fig 3. Anatomy of stomach 
 
Stomach wall has four basic layers: 
1. Mucous membrane 
2. Sub mucosa 
3. Muscular layer 
4. Serosa 
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                                                     HISTOLOGY: 
 
 
 
 
 
 
 
                                 Fig 4. Histology of stomach 
               The Helicobacter pylori colonizes in the mucous layer of the gastric 
antrum and is important in relevance to its possible etiology of peptic ulcer 
disease. 
Mucous membrane: 
            It is smooth and soft. To the naked eye, it appears as numerous folds 
(rugae) which disappear when stomach is distended. These rugae are most 
prominent  towards the body and greater curvature and are less apparent in the 
antrum. The lining epithelium is a single layer of columnar cells which secrete 
mucus and are  called“surface mucous cells”.  
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                 This surface epithelium dips into the lamina propria to form gastric 
pits. The mucosa is covered by a thick mucus layer, secreted from Surface 
mucous cells. The mucus acts as a lubricant and protects the stomach against its 
own acid and enzymes. 
                Damage to mucus layer exposes the stomach to gastric acid and active 
gastric enzymes and this is the basis of “Leaking Roof” hypothesis in the 
aetiology of peptic ulcers.22 
Gastric glands are three types: 
   1) Cardiac glands 
   2) Main gastric glands 
   3) Pyloric glands 
 
 
 
 
 
                                
                                 Fig 5. Different cells in gastric glands 
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1. Cardiac glands: 
           These are either simple tubular or tubulo-alveolar type confined to small 
area near the opening of oesophagus. They contain mainly mucus secreting 
cells. 
2. Main gastric glands: 
           They are present in the fundus and body of the stomach and they open 
into gastric pits. They contain the following cells. 
 
a. Chief cells: They are numerous in the basal parts of the glands. They secrete 
digestive enzymes like pepsin. 
b. Parietal cells (Oxyntic cells): They are numerous in the upper part of the 
gland. They are responsible for the secretion of hydrochloric acid and intrinsic 
factor. 
c. Mucous neck cells: They are present near the upper end of the gland and 
secrete mucous. Their secretions are different from that of the surface  mucous 
cells. 
d. Endocrine cells: These include somatostatin secreting D-cells and histamine 
secreting enterochromaffin-like cells. These are scattered throughout the glands. 
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e. Gastrin secreting cells (G-cells): Although small in number, they play a vital 
physiological role. They occur either singly or in small clusters in the mid to 
deep sections of antral glands. They contain basilar cytoplasm  densely packed 
with gastrin containing secretory granules. The apical or luminal surface of the 
G-cells is narrowed into small microvilli, which are thought to contain the 
receptors responsible for the amino acid and peptide stimulation for gastrin 
release. 
f. Undifferentiated cells: These are cells whose functions are not exactly known 
hence termed as undifferentiated cells. 
 
3. Pyloric glands: 
These are present in the antrum and pylorus. These extensively coiled glands are 
composed of endocrine, mucous and parietal cells. Mucous cells predominate in  
these glands. 
 
  
 
 
21 
 
PHYSIOLOGY: 
       The cells of gastric glands secrete about 2500ml of gastric juice daily. The 
juice contains mainly hydrochloric acid, pepsin, intrinsic factor, electrolytes and 
mucus. 
       Hydrochloric acid is produced by parietal cells in the body of stomach. It 
kills many ingested bacteria, provides the necessary pH for the pepsin to start 
protein digestion and stimulates the secretion of bile and pancreatic juice.23 
      The gastric mucosa is protected from the acid and pepsin by mucus content 
of gastric juice which forms a flexible gel that coats the mucosa. The surface 
mucous cells also secrete bicarbonate ions which are trapped in the mucus gel, 
so that the  pH gradient which is established ranges from pH 1-2 at the luminal 
side, to pH 6-7 at the surface of the epithelial cells. The surface membrane of 
the mucosal cells and  tight junctions between the cells are also part of the 
mucosal barrier, which prevents  the back diffusion of H+ ions and protects the 
epithelium from damage. 
       Helicobacter pylori colonizes the mucus layer of the stomach which 
provides the ecological niche in the antrum, which is conducive for its 
habitations. The break down of mucus layer and damage to surface epithelial 
cells are the basis of „Leaking roof‟ hypothesis of the pathogenesis of 
Helicobacter pylori.22 
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Regulation of gastric secretion:    
               Gastric motility and secretion are regulated by neural and hormonal 
mechanisms 
a) The neural component: It comprises of; 
               1. Local autonomic reflexes involving cholinergic neurons. 
               2. Impulses from the CNS by the way of Vagus nerves. 
b) The hormonal component: It involves various gastro intestinal hormones like  
gastrin, cholecystokinin and secretin. 
Secretion of gastric juice has three interconnected phases: 
1. Cephalic phase 
2. Gastric phase 
3. Intestinal phase 
 
Cephalic phase: 
   Cephalic phase of gastric acid secretion acts by stimulating the vagal centre 
via  the hypothalamus. Parietal and Chief cells are affected by direct cholinergic 
stimulation. 
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Gastric phase: 
              It starts by food entering and distending the stomach. Local and 
vasovagal distention reflexes stimulate the acid secretion of the stomach. 
Gastrin is released from the specialised „G‟ cells of the antrum of stomach in 
response to food in the stomach and gastric distention. Gastrin then stimulates 
the acid secretion by the parietal cells in the body of the stomach. 
 
Intestinal phase: 
             Gastric secretion is stimulated by food and its digestive products in the 
intestine. This may be due to stimulation of neuro-receptors and release of 
intestinal gastrin. In contrast acidification of the duodenum and the antrum 
results in inhibition of further acid secretion. This may be due to vagal 
inhibition or release of secretin or CCK-Pz(cholecystokininpancreozymin). 
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                     HISTORY & DEVELOPMENT OF ENDOSCOPY                                                              
As early as the 19th Century, attempts were been made to examine the interior 
of the upper GIT by reflecting light in to the body cavities through a hollow 
cylinder, but it was not until Thomas Edison‟s invention of the incandescent 
light bulb that it became possible in the late 1870‟s to perform rigid endoscopy. 
               Nevertheless progressively smaller lamps were developed that allowed 
insertion into the stomach through rigid endoscopes, but the nature of the light 
made it impossible to perform long or complex studies due to overheating of the 
instruments. 
               In addition the inability to adapt rigid instruments to the curvatures of 
the bowel permitted only limited examination of the upper GI tract. 
              These procedures were mostly performed by surgeons, such as the 19
th
 
Century Polish surgeon Johann Von Mikulicz-Radecki. 
              The era of flexible endoscopy began with the introduction of the semi 
rigid gastroscope by R.Schindler in 1936 through work developed in 
collaboration with the German physician Georg Wolf. The way to the 
development of a flexible fiberscope was paved by Baird‟s demonstration in 
1928 that light and images could be transmitted through a single glass or quartz 
fiber. 
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                In 1950‟s when Van Heel in the Netherlands and H.Hopkins and 
N.S.Kapany in England working independently, developed usable flexible glass 
fiber bundles that could transmit light across relatively long distance and into 
the body cavities. 
              The next phase of development took place in Ann Arbor at the 
University of Michigan, Physicians H.M.Pollard and Basil Hirschowitz , 
C.Wilbur Peters in collaboration with Physics students Lawrence Curtis, 
designed the first clinically useable, completely flexible endoscope. 
              Hirschowitz and Curtis started working on this concept in 1955 by 
developing an instrument composed of a bundle of individual glass fibres that 
was in theoretical capable of transmitting light as well as images. 
              Along the way, then encountered numerous problems such as fiber 
“Crosstalk”, which differed the light, making interpretation of the images 
impossible. 
             This led to the invention of a glass coating for the fibres for insulation 
and to the development of fiber scope. 
             The first controllable tip gastroscope was developed in 1962 and in 
contrast to the most landmark inventions, was first applied clinically and then 
found an industrial application in the examination of jet engines. 
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             After trying the flexible gastroscope on himself, Hirschowitz first used 
it in a patient with a bleeding duodenal ulcer in February 1957. The diagnosis 
was successfully established, and the patient underwent operation based on 
Hirschowitz observations. 
           The first commercially produced fiberoptic endoscope made by 
American cystoscope makers Inc, Norwalk, CT. was first used in 1961 and the 
results were published in the Lancet in may of that year. 
           Once the development and wide spread use of fiberoptic upper GI 
endoscope became a routine practice, the therapeutic potential was established. 
Experimental studies, such as those by W.D.Blackwood, S.Silivis, J.P.Papp, 
C.Sugawa and others demonstrated the feasibility and safety of endoscopic 
haemostasis. 
 
                   This has paved the way for the use of endoscopes as vehicle for 
numerous accessories so that today endoscopic surgery include methods of 
haemostasis, excision, ablation, dilatation, decompression, sclerosis and foreign 
body removal.25 
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INSTRUMENTATION 
            Flexible endoscope come in a variety of diameter and lengths, either 
direct-viewing or video. The primary endoscope used for upper GI endoscopy is 
a zero degree, forward viewing endoscope, where as duodenoscope visualizes 
the GI tract at 90º to the shaft. Side viewing endoscope is primarily used in the 
duodenum to visualise the ampulla of Vater, but they may also be used in the 
stomach. 
           All endoscopes are either video or fibreoptic and all have a control head. 
In the fiberoptic units, an eye piece is present for either direct visualization or 
for video attachment. 
          The shaft of the endoscope is flexible, especially at the distal tip, which 
has deflection capabilities ranging from 90-240 in the up/down position and 100 
in right or left directions. The diameter of the insertion tube can range between 
5.5mm to the distal tip to 11mm for a therapeutic endoscope. The diameter of 
insertion tube for duodenoscope ranges between 11.5 to 12.5mm. 
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            The controls for maneuvring the deflection tip are located on the 
control head with a large inner knob producing up or down deflection and the 
smaller outer knob producing a left or right deflection. Two depressable buttons 
are located adjacent to these deflection knobs and when pressed the top button 
produces suction that may  be necessary during the examination. The lower 
button serves two additional   functions. Air insufflations occurs by simple 
placement of a finger over the button without applying pressure. When this 
button is depressed a small amount of water is released.From the tip of the 
endoscope that is useful for cleaning the tip during the examination if it 
becomes dirty. 
              In the video endoscope, video control buttons on the top of the control 
head are used to freeze an image on the video screen or to save the image for 
printing.The flexible shaft is usually 110-120cms in length. This endoscope 
contain a working channel that varies between 2mm (paediatric endoscope) to 
3.7mm(therapeutic endoscope). On the other hand the instrument channel in the 
duodenoscope varies from 3.2-4.2mm. 
              Biopsy forceps, cytology brushes, or other diagnostic instruments are 
passed through the accessory channel. A double lumen therapeutic endoscope is 
also available for more advanced therapeutic endoscopy. 
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                     The flexible endoscope is connected to a light source that is either 
300W Xenon arc lamp or a halogen- tungsten lamp. In addition, air and water 
pumps for insufflations, suction and irrigation are connected to the endoscope 
via the light source unit and controlled using the control buttons. 
              If a video monitor is being used, this is also connected to the endoscope 
through the light source. 
              Proper hand positioning and manipulation of the flexible endoscope is 
key to perform an efficient examination. Most endoscopists will hold the control 
head of the endoscope in the left hand, with the thumb on the up/down knob and 
the index and middle finger on the suction and air/water button. The thumb & 
index finger are then used to control the deflection tip during examination. The 
right hand of the endoscopist is used to hold the flexible shaft for insertion, 
withdraw and rotation during the examination.26 
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                                     Fig 6. Parts of the endoscope 
UPPER GASTROINTESTINAL ENDOSCOPY 
PROCEDURE: 
PRINCIPLES:  
         Upper GI endoscopy plays a dominant role in the examination of the 
upper GI tract. It provides both direct & complete visualization of the  area and 
direct access for  tissue sampling and/or therapeutic intervention.  
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This should be mastered by any clinician with a special interest in diseases of 
the esophagus, stomach and duodenum. 
 
PATIENT PREPARATION: 
         The procedure is explained to patient in simple terms. During the clinical 
evaluation , allergies, current medication and previous medical history are 
reviewed, the need for antibiotic prophylaxis is assessed. 
         The patient should fast over night before the procedure. Out patients 
should be accompanied, particularly if intra venous sedation is to be used. 
         Having a calm & relaxed patient avoids to some extent the need for 
sedation. A tense patient should not be submitted to endoscopy under simple 
topical anaesthesia. Proper sedation dictates the use of pulse oximetry and ECG. 
A Lignocain gargle or spray is used for topical anaesthesia of the pharynx and 
hypopharynx. 
          When needed,adequate sedation may be obtained with 
benzodiazepines (diazepam, midazolam). Pethedine hydrochloride may be 
added for relaxation and analgesia. This medication should be administered 
slowly in small doses until the desired level of sedation is obtained. 
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TECHNIQUE 
INTRODUCTION OF THE ENDOSCOPE: 
         The patient lies in the left lateral decubitus position. Following appropriate 
topical anaesthesia, a mouth piece is postioned between upper and lower teeth. 
Endoscope is advanced, taking care to stay on the midline and at the interface 
between the tongue and hypopharyngeal mucosa. Tongue, uvula, epiglottis and 
cricoarytenoid cartilages are seen. Passing beside the midline, the cricoarytenoid 
cartilages are passed and the tip of the endoscope stops on the cricopharyngeus. 
Gentle local pressure while asking the patient to swallow allows the tip of the 
endoscope to pass into the cervical esophagus. 
 
EXAMINATION OF ESOPHAGUS: 
         The instrument is advanced under direct vision, with the tip of the 
endoscope always central in the lumen. Using the optimal insufflations to keep 
the lumen of the esophagus well distended. 
         First hand inspection is important, because no trauma has caused by the 
manipulation or passage of the instrument. 
Two rules should always be followed: 
1. Endoscope must advanced with clear vision of the central lumen. 
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         2. If direct vision is obscured or there are any doubts, the endoscope 
should be withdrawn. 
          
          Land marks distal to cricopharyngeal sphincter are extra luminal 
compression of left main bronchus, aortic arch and pulsations of left heart in the 
distal half. 
          The gastro-esophageal mucosal junction is usually identified at 38-40cms 
from the incisors. This junction is usually serrated and readily identified by the 
color difference between the esophageal and gastric mucosa, called as Z line. 
           
         The position of the esophageal hiatus in the diaphragm is identified by 
asking the patient to inhale deeply, the diaphragmatic hiatus during inspiration 
creates an imprint on the esophageal and gastric wall. The position of both the 
hiatus and the mucosal junction are recorded in order to document the 
possibility of a hernia or of a columnar lined esophagus. 
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 PASSAGE IN TO THE STOMACH: 
        Gastro-esophageal junction should be observed for closed or widely 
patulous. Passage in to the gastric lumen is usually a simple manoeuvre that 
occurs without resistance. 
        On entering the stomach, it becomes distended with air and this often 
causes discomfort to the patient. By tipping the end of the endoscope slightly 
down and towards the left, a view of greater curvature and of the posterior wall 
is obtained. Aspiration of all retained liquid is done to reduce the risk of 
aspiration & to allow proper examination of the stomach. A rotation movement 
of the tip of the instrument allows examination of the anterior and posterior 
walls of the body of the stomach. The lesser curvature down to the angulus and 
the greater curvature are viewed by the same position motion. The most 
proximal part of both curvatures are better examined when using the J 
manoeuvre. 
        By rotating and angulating the tip endoscope is advanced to assess the 
antrum. Prepyloric and pyloric ring observed directly, the passage through the 
pylorus being done under direct vision. When the pylorus yields, complete 
assessment of the first part of the duodenum is done as far as the superior 
duodenal angle. While the tip of the endoscope lies along the distal lesser 
curvature and while the stomach is distended, rotation of the instrument is 
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accomplished towards the greater curvature, complete 180 degree upwards 
angulation of the endoscope tip completes the J manoeuvre. 
                The endoscope is pulled back while the stomach is distended, from 
the cardia to angulus. swinging of the retroflexed tip allows proper visualization 
of the stomach. Simultaneous rotation of the endoscope gives excellent view of 
the lesser curvature 
             After straightening the tip endoscope is gently pulled back examining 
the esophagus again. Patients are encouraged to avoid drinking or eating for 
approximately 30mins after the procedure.26 
ENDOSCOPIC BIOPSY: 
            Typical lesions routinely evaluated by biopsy are esophageal strictures, 
mass lesions, gastroduodenal ulcers, gastroduodenitis and polyps. Diagnostic 
yield increases when multiple specimens are taken of any suspicious lesion, if 
one  suspects a malignancy, six biopsy specimens and cytology will increase 
diagnostic  accuracy to better than 90-95% lesions arousing suspicion for being 
varices should  not be biopsied, as this can lead to significant bleeding. 
            Biopsy forceps come in many shapes and sizes. The biopsy instrument is 
passed through the working channel, and once the tip is visible the jaws are 
opened, pushed into the mucosa, closed and then quickly pulled back, bringing 
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with them an adequate specimen. Biopsy forceps containing a spike can be used 
to obtain multiple specimens without having to remove it from the endoscope. 
              Biopsies for gastric ulcers should typically be taken in all four 
quadrants and at the base of the ulcer. The transition zone between the ulcer and 
surrounding mucosa is the area that most likely contains increased mitotic 
activity in malignant ulcers and therefore biopsy of this region improves 
diagnostic yield. 
               Biopsies of submucosal masses can have limited yield because the 
submucosal location is not easily reached. To increase yield several biopsies 
should be taken. Caution is the rule – because the area can become weakened 
and be at risk for perforation. 
         Esophageal stricture, such as demonstrate dysplasia or malignant 
transformation and specimen obtained. Polyps in the stomach or duodenum can 
be cancerous and should be sampled, either hot or cold biopsy forceps can 
remove diminutive polyps less than 5mm in diameter. Whereas a snare is best 
for larger polyps. The snare is placed at the base of a pedunculated polyp, and 
the polyp is removed in piecemeal fashion. 
          Japanese investigators have developed technique for lesion removal 
where by a suction apparatus is passed through the endoscope and lesion is 
grasped with suction. A snare is then placed around the base of the lesion & 
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closed tightly and removal of the specimen is possible. If significant bleeding 
results, standard coagulation technique can be employed.26 
PROGRESS OF INTRAGASTRIC OBSERVATION THROUGH THE 
FIBEROSCOPE: 
1. Simplification of the technique of intra gastric observation based on direct 
vision. 
2. Elimination of blind spots. 
3. Regulation of various endoscopic conditions. 
4. Advance in observing fine changes through close up observation. 
5. Improvement of recording ability by aiming recording photography 
equipment. 
6. Revolutionizing the technique of biopsy on direct vision through the use of 
fiberscope. 
7. Progress in diagnosing cancer cells by viewing cells according to the direct 
vision method with the fiberscope. 
8. Precise observation through the application of supplemental techniques,such 
as washing the lesion and applying a pigment solution.. 
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DYSPEPSIA: Definition and prevalence 
         Dyspepsia (from the Greek  (Dys-), meaning hard or difficult, and   
(Pepse), meaning digestion) is chronic or recurrent pain or discomfort centered 
in the upper abdomen.28,29 Discomfort, in this context, includes mild pain, 
upper abdominal fullness and feeling full earlier than expected with eating. It 
can be accompanied by bloating, belching, nausea or heartburn. It may be called  
indigestion. Heartburn is excluded from the definition of dyspepsia in ICD-10, 
as it usually has a different cause and management pathway. When a patient has 
dyspepsia, but no underlying disease is found, the patient is said to have non-
ulcer dyspepsia or functional dyspepsia or idiopathic dyspepsia. 
Classification: 
Dyspepsia has been proposed to have symptomatic subgroups.30,31,32 
 Ulcer like - Pain centered in the upper abdomen is the predominant (most 
bothersome) symptom. 
 Dysmotility like - An unpleasant or troublesome non-painful sensation 
(discomfort) centered in the upper abdomen is the predominant symptom; 
this sensation may be characterized by or associated with upper 
abdominal fullness, early satiety, bloating, or nausea. 
 Reflux like 
 Nonspecific. 
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     Dyspepsia occurs in 40% of the population, leads to General practitioner 
consultation in 5% and referral for endoscopy in 1% of the population annually. 
In patients with signs or symptoms severe enough to merit endoscopy, 40% 
have functional or non-ulcer dyspepsia, 40% have gastro-esophageal reflux 
disease and 13% have some form of ulcer.33 Alarm features or red flags that 
may indicate serious underlying diseases are:34 
 Age older than 55 years with new-onset dyspepsia 
 
 Family history of upper gastrointestinal cancer 
 
 Unintended weight loss 
 
 Gastrointestinal bleeding 
 
 Progressive dysphagia 
 Odynophagia 
 Unexplained iron-deficiency anemia 
 Persistent vomiting 
 Palpable mass or lymphadenopathy 
 Jaundice 
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ETIOLOGY: 
Etiology can be broadly classified into 2 main groups34 
Structural abnormalities. 
Functional (Non ulcer) dyspepsia. 
STRUCTURAL ABNORMALTIES: 
Hiatus hernia. 
Gastro-esophageal reflux disease (GERD). 
Barrett‟s esophagus. 
Peptic ulcer disease. 
Esophageal, gastric and duodenal cancer. 
 
 HIATUS HERNIA: 
            A hiatus hernia occurs when part of the stomach moves up in to the 
chest through a defect in the diaphragm. It is a common problem occurring in 
10% of people and the hernia rarely causes symptoms on its own. The presence 
of a hiatus hernia can cause weakness of the lower esophageal sphincter and this 
in turn can cause reflux of the acidic stomach contents into the esophagus. 
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          This causes the sensation of heartburn and patients with a hiatus hernia 
are more prone to heartburn than those without this defect. Nevertheless it is 
important to emphasise that not all patients with hiatus hernia have heartburn 
and some patients with heartburn do not have a hiatus hernia. 
GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD): 
         Gastro-esophageal reflux may occur when the pressure of the high-
pressure zone in the distal esophagus is too low to prevent gastric contents from 
entering the esophagus or when a sphincter with normal pressure undergoes 
spontaneous relaxation, not associated with a peristaltic wave in the body of the 
esophagus. GERD is often associated with a hiatus hernia. 
              The most common presentation of patients with GERD is a long-
standing heartburn and a shorter history of regurgitation. Heartburn, when 
typical, is a very reliable symptom. Heartburn is confined to the epigastric and 
retrosternal areas. It is identified as a caustic or stinging sensation. It does not 
radiate to the back and is not characteristically described as a pressure sensation. 
BARRETT‟S ESOPHAGUS: 
       In some patients, prolonged acid and perhaps alkaline injury leads to a 
change in the esophageal mucosa from its usual squamous epithelium to a 
columnar configuration (Barrett's esophagus). The cells almost always extend 
proximally from the squamo columnar junction in a contiguous pattern. 
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 If  Barrett's esophagus is  found,multiple biopsies are necessary to exclude 
dysplasia, which may indicate a  tendency toward the development of 
adenocarcinoma. 
      Although the incidence of adenocarcinoma in patients with Barrett's 
esophagus is  about 40 times greater than that in the general population 
(Barrett's studies with increased incidence), the incidence of cancer in these 
patients is still very low. 
       Because Barrett's esophagus arises from gastro-esophageal reflux injury (of 
acid or bile), Long segment Barrett‟s esophagus, diagnosed when at least 3cm 
of the distal esophagus is lined by columnar epithelium, has greatest malignant 
potential  and surveillance is recommended for this disorder. Short segment 
Barrett‟s esophagus, for less than 3cm of columnar lined esophageal mucosa, is 
thought to have a lower malignant potential and the role of surveillance is 
uncertain. Although no columnar lining may be visible, intestinal metaplasia 
may be found in biopsies taken at the gastro-esophageal junction. While 20% of 
the population have evidence of intestinal metaplasia at the gastro-esophageal 
junction, again the malignant potential of this lesion is uncertain and 
surveillance is not recommended. 
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PEPTIC ULCER DISEASE (PUD): 
           Ulcer is caused by acid peptic digestion of the mucosa to variable depth 
either in mucosa containing acid secreting cells or in other sites. Peptic ulcer 
extends through the muscularis mucosa, an erosion is superficial to the 
muscularis mucosa. 
 
           Although the name suggests an association with pepsin, it is the acid 
which is important for the occurrence of peptic ulcer. May be acute ulcers 
which are shallow and multiple or chronic which are single, deep and scirrhous. 
 
Common sites: 
          1. 1st part of duodenum 
          2. Lesser curve of stomach 
          3. Prepyloric and pyloric channel 
 
Gastric ulcer: 
        Seen commonly in late middle age and the incidence increases  with age.  
Sex incidence is found to be equal. 
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Duodenal ulcer:  
           Most common in middle age, more common in males. Male to female 
ratio  was found to be 3:1. 10 - 20% of patients with a gastric ulcer may have 
concomitant duodenal ulcer. 
Etiology: 
1. Helicobacter pylori infection 
2. Endocrine – 
             a) Zollinger-Ellison syndrome b) Cushings syndrome 
             c)Parathyroid tumour - hypercalcemia 
3. Genetic: cases with blood group „O‟ 
4. Drugs : NSAIDS, aspirin, steroids 
5. Smoking: 
             a) Predispose to ulcer formation 
             b)Increases the relapse rate after treatment. 
6. Alcohol7. Diet: irregular diet, spicy food and excessive intake of coffee and 
tea provoke the formation of peptic ulcer. 
8. Emotional factors: anxiety, stress have always been incriminated to cause 
peptic ulcer. 
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Pathogenesis: 
1. Loss of mucosal defense with hyperacidity 
2. Gastric mucus is an important barrier that protects the gastric mucosa from 
the effects of acid and pepsin. 
3. Decreased bicarbonate concentration 
4. Decreased gastric mucosal prostaglandin production 
5. Acid overproduction is an important factor for causing DU. 
 
H.pylori: 
         It is the most important factor in the development of peptic ulcer. Fifty 
percent of the world's population is infected with H. pylori, a major cause of 
chronic gastritis. Helicobacter also clearly has an etiologic role in the 
development of gastric lymphoma. H.pylori is a small curved, motile, Gram 
negative, microaerophilic rod with multiple polar flagellae. In stomach it 
remains close to the gastric mucus secreting cells. 
 
It hydrolyses urea                   ammonia                     increased gastrin. 
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ESOPHAGEAL AND GASTRIC CANCER: 
       Gastric and esophageal cancers are rare, accounting annually for 1% of 
deaths from all causes. Gastric cancer is on the decline, while esophageal cancer 
is on the increase. Gastric cancer may be declining because of the decreasing 
prevalence of H.pylori. Squamous cell carcinoma and adenocarcinoma account 
for 95% of all esophageal tumours. Traditionally squamous carcinoma was the 
most frequent lesion but in recent years adenocarcinoma has become the 
predominant disease. 
       Adenocarcinoma of the esophagus is believed to originate from columnar 
metaplasia of the esophagus (Barrett‟s esophagus), providing a rationale for 
endoscopic screening of patient‟s with Barrett‟s esophagus.Adenocarcinoma is 
responsible for over 95% of all gastric malignancies. Half of patients are 
inoperable at the time of diagnose and few of these survive five years,while of 
those undergoing operative treatment 20% are alive after 5 years. Overall 5 year 
mortality for this disease is therefore approximately 90%. Gastric neoplasia is 
strongly associated with H.pylori infection but as the vast majority of H.pylori 
infected individuals do not develop gastric carcinoma other environmental  and 
genetic factors must be important.33 
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FUNCTIONAL (NON ULCER) DYSPEPSIA: 
           Functional gastrointestinal disorders include a variable combination of 
chronic or recurrent gastrointestinal symptoms that do not appear to be 
explained by structural or biochemical abnormalities. These functional disorders 
include symptoms attributed to dysfunction of the oropharynx, esophagus, 
stomach, small  bowel, large bowel and biliary tract. 
           Non-ulcer dyspepsia is a heterogeneous syndrome. It has been proposed 
that this entity can be subdivided into a number of symptomatic clusters or 
groupings that suggest possible underlying pathogenetic mechanisms. These 
groupings include ulcer-like dyspepsia (typical symptoms of peptic ulcer are 
present), dysmotility (stasis)- dyspepsia (symptoms include nausea, early 
satiety, bloating, and belching that suggest gastric stasis or small intestinal 
dysmotility), and reflux-like dyspepsia (heartburn or acid regurgitation 
accompanies upper abdominal pain or discomfort).likely a multifactorial 
disorder. Motility abnormalities may be important in a subset of dyspepsia 
patients but probably do not explain the symptoms in the majority. 
          Epidemiological studies have not convincingly demonstrated an 
association between Helicobacter pylori and The etiology of non-ulcer 
dyspepsia is not established, although it is non-ulcer dyspepsia. Other potential 
etiological mechanisms, such as increased gastric acid secretion, psychological 
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factors, life-event stress, and dietary factors, have not been established as causes 
of non-ulcer dyspepsia.34 
 
OTHER CAUSES: 
1. Biliary or pancreatic diseases. 
2. Metabolic disturbances. 
3. Irritable bowel disease. 
4. Psychiatric diseases. 
INVESTIGATIONS:20 
UPPER GI ENDOSCOPY: Endoscope is used to visualize the esophagus, 
stomach and proximal duodenum, if necessary therapeutic procedures can be 
perform. 
          Endoscopy has now become the gold standard test for detecting 
esophageal, gastric and duodenal lesions. 
Investigations for H.pylori infection: 
          Tests for Helicobacter pylori may be divided into those that require 
endoscopy (invasive tests) and those that do not require endoscopy (non-
invasive tests). 
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Invasive tests: 
a. Histology 
b. Culture 
c. Rapid urease test (RUT) 
d. Cytology 
e. Polymerase chain reaction (PCR) 
Non-invasive tests: 
a) Serology. 
b) Urea breath tests. 
c) Faecal antigen testing. 
TREATMENT 
1. Reassurance. 
2. Pharmacological treatment: 
a) H 2 receptor blockers- Ranitidine 150mg bid. 
b) Proton pump inhibitors- Omeprazole 20mg, Rabeprazole 20mg, 
Pantoprazole 40mg. 
c) Antacids and alginates- Aluminium hydroxide, Magnesium trisilicate, 
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Dimeticone and Peppermint oil. 
d) Prostaglandin analogues- Misoprostol. 
e) Prokinetics- Domperidone and Cisapride 
 
SURGICAL PROCEDURES: 21 
              The discovery of H.pylori and the development of powerful acid 
suppressive therapy have revolutionized the medical therapy of peptic ulcer and 
gastro- esophageal reflux disease. This has made peptic ulcer surgery almost 
obsolete.  
               Anti-reflux surgery is reserved for selected patients with documented 
acid reflux whose symptoms are unresponsive to medical therapy or who do not 
wish to take long termPPI treatment. 
 
ANTI-REFLUX SURGERY 
FUNDOPLICATION (OPEN OR LAPROSCOPIC APPROACH) 
a) Nissen fundoplication (360- degree wrap)- most common anti-reflux surgery. 
b) Partial anterior fundoplication. 
c) Partial posterior fundoplication. 
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ENDOSCOPIC THERAPY: 
                   Recently, several endoscopic techniques have been developed for 
the treatment of GERD. These procedures have sparked significant interest 
because they each promise a mechanical treatment for reflux with less invasion 
than a fundoplication.  
                     These techniques attempt to augment the LES by suturing, 
radiofrequency energy, Plexiglas injection or biocompatible polymer injection. 
 
PEPTIC ULCER SURGERY 
a) TRUNCAL VAGOTOMY: Division of both vagus nerves above the hepatic 
& celiac branches just above the GE junction. This procedure is usually 
combined with drainage procedure. 
             - Gastrojejunostomy 
             - Pyloroplasty 
b) SELECTIVE VAGOTOMY: Division of both vagus below the hepatic & 
celiac branches. 
 
c) HIGHLY SELECTIVE VAGOTOMY (HSV):Also called parietal cell or 
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proximal gastric vagotomy. Severs vagal nerve supply to proximal 2/3rd of the 
stomach and preserves vagal innervation to the antrum and Recurrence rate 5 to  
10%. pylorus. 
 
GASTROJEUJUNOSTOMY: Ananstomosis between proximal jejunum and the 
most dependant portion of greater curvature of the stomach. Anastomosis is  
antecolic / retrocolic, isoperistaltic, no loop, no tension. 
 
VAGOTOMY + ANTRECTOMY (This procedure has got the lowest 
recurrence rate < 2%). 
Billroth I reconstruction (Gastroduodenostomy). 
Roux-en-Y Gastrojejunostomy. 
 
PYLOROPLASTY: 
a) Heineke-Mikulicz pyloroplasty involves a longitudinal incision of the pyloric 
sphincter followed by a transverse closure. Most commonly performed 
pyloroplasty. 
b) The Finney pyloroplasty is performed as a gastroduodenostomy with division 
of the pylorus. 
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c) The Jaboulay pyloroplasty differs from the Finney procedure in that the 
pylorus is not transected. 
SURGERY FOR GASTRIC CANCER: 
1.Endoscopic mucosal resection (EMR). 
2.Endoscopic submucosal dissection (ESD). 
3.Wedge resection. 
4.Open gastrectomy (Partial/ subtotal). 
5.Laparoscopically assisted gastrectomy (Partial/ subtotal). 
LYMPH NODE LEVELS: 
N 1 : Peri gastric nodes. 
N 2 : Nodes along the vessels. 
N 3 : Distant nodes. 
EXTENT OF LYMPHADENECTOMY: 
 Resection: Removal of tumour and N1 nodes. 
d N1, N2 nodes also removes the 
peritoneal layer over the pancreas and anterior mesocolon. 
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SURGERY FOR ESOPHAGEAL CANCER: ESOPHAGECTOMY 
-hiatal Approach: The trans-hiatal esophagectomy is performed 
through an upper midline laparotomy and left cervical incision. 
-abdominal, trans-thoracic approach. 
Three-Field Esophagectomy: This approach is carried out through separate 
laparotomy, right thoracotomy, and cervical incisions. 
ft thoracoabdominal approach is 
probably the least utilized of all approaches to the esophagus. 
techniques laparoscopic, esophagectomy. To esophagectomy, hand-
assisted,have been described. And These include thoracoscopic, robotic-assisted 
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                                             METHODOLOGY 
                 A prospective clinical study was undertaken at general surgery 
department, RajivGandhi Government General Hospital attached to Madras 
Medical College ,  to know the various upper gastro-intestinal endoscopic 
findings in patients presenting with late onset dyspepsia at RGGGH, Chennai”. 
The study was conducted  over a period of 6 months(June 2013 to Nov 2013). 
The patient selection was by convenience sampling. 
                Dyspeptic patients were included in this study with their informed 
consent. A detailed clinically history was elucidated, followed by careful 
clinical examination, which were recorded as per the proforma. All the patients 
included in the study underwent upper gastrointestinal endoscopy and the 
findings were noted. 
 
INCLUSION CRITERIA: 
    1) patient age above 40yrs with dyspeptic symptoms. 
    2) Patient with alarm symptoms.  
    3) Patient with previously diagnosed and treated cases of gastric ulcer, 
duodenal ulcer, complicated peptic ulcer, coming with dyspeptic symptoms. 
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EXCLUSION CRITERIA: 
   1) Patients who are endoscopy negative but have dyspepsia, may have 
motility disorders.  
   2) Individuals who had an endoscopy indications other than dyspepsia. 
    3) Not willing for endoscopy. 
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PROCEDURE: 
            All the patients in this study group, on outpatient basis underwent upper 
gastro-intestinal endoscopy under topical anesthesia. The patients were asked to  
fast for 12 hours prior to the procedure. Only a few patients were given 5-10mg 
diazepam intravenously for sedation. 
           Lignocaine viscous or oral lignocaine sprays were given to the patient 5-
10 minutes before the procedure for the local anaesthetic effect. The upper 
gastro-intestinal endoscopy was conducted with  flexible, fibreoptic endoscope 
with patients in left lateral positions. 
          The instrument is advanced under direct vision, with the tip of the 
endoscope in central lumen. Using the optimal insufflations to keep the lumen 
of the esophagus well distended. Esophagus was looked for any inflammatory 
changes, growth. The gastro-esophageal mucosal junction was identified at 38-
40cms from the incisors.(This junction is usually serrated and readily identified 
by the color difference between the esophageal and gastric mucosa, called as Z 
line). 
          The position of the esophageal hiatus in the diaphragm is identified by 
asking the patient to inhale deeply, the diaphragmatic hiatus during inspiration 
creates an imprint on the esophageal and gastric wall. The position of both the 
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hiatus and the mucosal junction are recorded in order to document the 
possibility of a hernia or of a columnar lined esophagus. 
              Gastro-esophageal junction should be observed for  closed or widely 
patulous. On entering the stomach, endoscope slightly down and towards the 
left, a view of greater curvature and of the posterior wall is obtained.  
               Aspiration of all retained liquid is done to reduce the risk of aspiration 
and to allow  proper examination of the stomach. A rotation movement of the 
tip of the instrument  allows examination of the anterior and posterior walls of 
the body of the stomach. The lesser curvature down to the angulus and the 
greater curvature are viewed by the same position motion. The most proximal 
part of both the curvatures are better examined when using the J manoeuvre. 
Stomach was looked for inflammatory  changes, ulcer, growth. 
          By rotating and angulating the tip endoscope is advanced to assess the 
antrum. Prepyloric and pyloric ring observed directly, the passage through the 
pylorus being done under direct vision. When the pylorus yields, complete 
assessment of the duodenum is done upto second part. 
         Two endoscopic biopsies were taken, 2 each from the gastric antrum and 
the abnormal looking area. The edge of the ulcer crater depending on the 
findings. The biopsies from the body and the antrum were randomly taken in 
cases where in the endoscopic findings were normal.                 
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Flexible Optic Endoscopy:         
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           Endoscopic view of gastric ulcer                    Esophageal carcinoma 
 
 
 
 
                Gastric ulcer with carcinoma                    Antral gastric ulcer 
 
 
 
 
                  Gastric antral gastritis                            bile reflex gastritis 
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       Endoscopic view of duodenal  ulcer                            Endoscopic view of Barrett’s 
                                                                                                  
 
 
 
 
                                             Endoscopic view of Lax LES 
                                                                  (hiatus hernia) 
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                               Endoscopic biopsy instrument 
 
    
                                            Endoscopic biopsy 
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                                                    RESULTS 
               Out of 200 patients, there were 118 (59%) male patients, 82 (41%) 
female patients, age ranging from 40 years to 80 years. The mean age of the 
patients in this study was found to be 60 years. 
             All these patients presented to our hospital with symptoms of dyspepsia 
for 4 or more than 4 weeks. Upper GI endoscopy was done in all patients. 
        Table-1    Various endoscopic finding  in patients with dyspepsia 
s.no       Endoscopic finding    Male(%)   Female(%)   Total(%) 
1 Normal 20 15 35(17.5%) 
2 Esophagitis 8 4 12(6%) 
3 Esophageal polyp 1 2 3(1.5%) 
4 Hiatus hernia 6 4 10(5%) 
5 GERD 17 18 35(17.5%) 
6 Barrett‟s esophagus 1 0 1(0.5%) 
7 Carcinoma esophagus 1 1 2(1%) 
8 Gastritis 35 21 56(28%) 
9 Gastric ulcer 8 5 13(6.5%) 
10 Carcinoma stomach 8 3 11(5.5%) 
11 Esophagogastritis 5 2 7(3.5%) 
12 Duodenitis 2 3 5(2.5%) 
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13 Duodenal ulcer 3 3 6(2%) 
14 Gastroduodenitis 2 1 3(1.5%) 
15 Esophagogastroduodenitis 1 0 1(0.5%) 
          
                                  Total  
 
118(59%) 
 
82(41%) 
 
200 
 
 
Graph 1: Frequency of various diseases on endoscopy in patients 
presenting  with  dyspepsia 
 
                Normal study was observed in 35(17.5%) patients. Most common 
abnormal endoscopic finding was gastritis 56(28%) patients, followed by 
GERD in 35 (17.3%) of patients, esophagitis, hiatus hernia and duodenal ulcer, 
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which were present in 8(5.6%) patients each. Duodenitis in 5 (2.5%) patients, 
esophagogastritis and gastric ulcer were seen in 17 (8.5%) patients each.  
               Carcinoma stomach in 11 (6.5%) patients, gastroduodenitis in 3 
(1.5%) patients, carcinoma  esophagus in 2(1%) patients were noted Esophageal 
polyp, esophagogastroduodenitis and Barrett‟s esophagus present in 5 (2.5%) 
patient each, were the least common findings. 
 
AGE DISTRIBUTION;                 
                 Table 2: Incidence of dyspepsia in different age groups 
               
            Age groups 
       
          No of cases(%) 
 
                41-50 
 
                39.5% 
 
                51-60 
           
                32 % 
                
                61-70 
 
                19% 
 
                71-80 
 
                9.5% 
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                    Graph 2. Incidence of dyspepsia in different age group 
 
TABLE 3: Frequency of various diseases on endoscopy in different age group 
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  Age 
Groups 
 
Normal 
 study 
   
  H.H/ 
GERD 
 
  
 Inflm 
lesion 
    
   malig 
  
Ulcer/ 
dyspepsia 
   
  Total  
 
percentage 
41-50  15  17 36 2 9 79 39.5% 
51-60  10 18 25 5 6 64 32% 
61-70   7 7 18 4 2 38 19% 
71-80   3 3 9 2 2 19 9.5% 
TOTAL 
 
 
  35 
 
   45 
 
  88 
 
   13 
 
   19 
 
   200 
 
   100 
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Graph 3: Frequency of various diseases on endoscopy in different age group 
 
 
                      All patients were subdivided into different age groups. 
 -Most common clinically significant endoscopic findings were seen in 
age group  between 41-60 years. 
-Hiatus hernia GERD were commonly seen in the age group between 
41-60 years. 
-Inflammatory lesions (gastritis, esophagitis, eso polyp, Barrett’s 
esophagus, esophagogastritis, duodenitis, gastroduodenitis and 
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esophagogastroduodenitis) were commonly seen in the age group 
between 41-50 years. 
-Ulcer dyspepsia were commonly seen in the age group between 41-60 
years. 
-Malignant lesions were seen frequently in patients aged more than 50 
years. 
 
Table 4: Frequency of various diseases on endoscopy in males and females 
 
 
GENDER NORMAL 
  STUDY 
H.H/ 
GERD 
INFLA 
LESION 
MALIG ULCER TOTOL PERCEN 
      
TAGE 
MALE 20 
(16.9%) 
23 
(19.5%) 
55 
(46.6%) 
9 
(7.6%) 
11 
(9.3%) 
118 59% 
FEMALE 15 
(18.3%) 
22 
(26.8%) 
33 
(40.2%) 
4 
(4.8%) 
8 
(9.7%) 
82 41% 
TOTAL 35 
(17.5%) 
45 
(22.5%) 
88 
(44%) 
13 
(6.5%) 
19 
(9.5%) 
200 100% 
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       Graph-4 Frequency of various diseases on endoscopy in different  
                                            males and females 
 
         
                   Analysis of various diseases on endoscopy showed that the most 
common pathology was inflammatory lesions seen in 88 (44%) of patients, of 
which 55(46.6%) were male patients and 33 (40.2%) were female patients, 
followed by Hiatus hernia and GERD were next common abnormal findings, 45 
(22.5%) in thedecreasing order of the frequency of which 23 (19.5%) were 
males and 22 (26.8%) females. Ulcer dyspepsia was seen in 19 (6.5%) of 
which11 (9.3%) males and 8 (4%) females. Malignancy was common in males 
9 (7.6%) patients. 
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              Table-5  Prevalence of clinically significant endoscopic finding                                   
according to the site of lesions 
s.no           CSF‟s AGE 
41-60 
AGE 
61-80 
TOTAL PERCENTAGE 
1 ESOPHAGUS 39 14 53 32.1% 
2 STOMACH 68 22 90 54.5% 
3 DUODENUM 9 2 11 6.7% 
4 ESO+STO 5 2 7 4.2% 
5 STO+DUO 2 1 3 1.8% 
6 ESO+STO+DUO 1 0 1 0.6% 
 TOTAL 124 41 165 100% 
Graph-5 Prevalence of clinically significant endoscopic findings                                        
according to the site of lesion 
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                  Out of 165 patients with clinically significant endoscopic findings, 
mostcommon pathology was seen in stomach of 90 (54.5%), patients followed 
by esophagus 53 (32.1%) and duodenum 11 (6.7%). 
        
        Table-6  Frequency of various symptoms of dyspepsia in males and 
females 
 
 
 
 
 
s.no 
 
Clinical presentation 
 
male 
 
female 
 
total 
 
Percentage 
1 Epigastric pain 95 50 145 72.5% 
2 Heart burn 60 32 92 46% 
3 Nausea/vomiting 80 40 120 60% 
4 Food intolerance 59 31 90 45% 
5 Indigestion 52 26 78 39% 
6 Loss of weight/appetite 45 15 60 30% 
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       Graph-6    Frequency of various symptoms of dyspepsia in males and 
females 
 
 
 
           Out of 200 patients, the most common component of dyspepsia was  
epigastric pain and discomfort, seen in 145 (72.5%) patients, followed by  
nausea and/or vomiting 120(60%) patients, heart burn in 92 (46%) patients,  
food intolerance in 90 (45%) patients, indigestion in 78 (39%) patients and loss  
of appetite and/or weight in 60 (30%) patients. 
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                                                DISCUSSION 
                    A prospective clinico-pathological study entitled “A Clinical study 
of various findings in upper gastro-intestinal endoscopy in patients presenting 
with late onset dyspepsia at general surgery department, ”RajivGandhi Govt. 
General  Hospital” attached to Madras Medical College and Research Institute 
to study the  endoscopic findings of dyspepsia,  to detect 
esophagogastroduodenal carcinoma at early stages. 
           After informed consent 200 cases of dyspepsia were included in the 
study and were studied clinically as per the proforma over a period of one and 
half year from June 2013 to Nov 2013. All the patients underwent upper gastro-
intestinal endoscopy and various findings were noted. 
CLINICAL PRESENTATION: 
                        Out of 200 patients, 145 (72.5%) patients had epigastric pain and 
discomfort as their chief complaint  where as nausea and vomiting was present 
in120 (60%) patients. The other complaints were heart burn 92 (46%), food 
intolerance 90(45%), indigestion 78(39%) and loss of appetite and 
weight60(30%). 
                     Similar study was conducted by Thomson A B R et al, in which 
the common presenting complaints were upper abdominal pain (34.3%), heart 
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burn (24.5%) and acid regurgitation (13.3%),9 the observations were 
comparable with that of the present study. 
 
COMPARISON OF GENDER DISTRIBUTION 
                     In this study 59% were male patients, 41% were female patients.  
The incidence of different presentations of late onset dyspepsia were common in  
males  compared to females. Only the incidence of esophagogastritis was more  
in female patients. 
               The male / female ratio in the studies conducted by Khan N et al –  
2.3:1, Ziauddin- 1.6:1, Mustapha SK et al- 1.1:1 respectively. In these studies  
also the majority of patients were males as observed in our study.6,40,41 
                    In a population based study in Australia, female adults significantly  
out numbered males in most functional gastrointestinal disorders includes  
functional dyspepsia.42 
 
COMPARISON OF VARIOUS ENDOSCOPIC FINDINGS: 
            In the present study, clinically significant endoscopic findings were 
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observed in 165 patients accounting for 82.5%. Gastritis was by far the most 
common finding (28%), while GERD was found in 17.5%. The next common 
findings were esophagitis, gastric ulcer and duodenal ulcer accounting for 
12.5% each. 
           The percentage of cases with gastritis in this study was higher than that 
observed in studies by Sarwar et al and Ziauddin. The percentage of patients  
GERD was nearly equal to that observed by Sarwar et al. 
 
 
 
 
 
 
           
 
                                                              Table-7 
 
s.no Name of 
the study 
 
Gastritis 
 
Reflux 
esophagitis/ 
      GERD 
 
1 Sarwar et 
al.39 
 
13% 
 
20% 
 
2 Ziauddin40 
 
18% 
 
14% 
 
3 Present  28% 17.5% 
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COMPARISON OF INCIDENCE OF GASTRIC MALIGNANCIES: 
             In this study there were 11 patients with carcimona stomach accounting 
for 5%, among them which 8 were male patients. Gastric malignancies were 
common in older age groups. Incidence of gastric malignancies observed by 
  various authors are as follows: 
                                                                    
 
 
 
  
 
 
 
   
       Table-8   The incidence of gastric malignancy in these studies is 
comparable with the observed in the present study. 
s.no NAME OF STUDY 
 
%  GASTRIC/ 
MALIGNANCIES 
1 Choomsri P et al.5 
 
1% 
2 Khan N et al.6 
 
3% 
3 Ziauddin40 
 
4% 
4 Present study 6.5% 
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                                               CONCLUSION 
               From the present study of “A clinical study of various findings in 
upper gastro-intestinal endoscopy in patients presenting with late onset  
dyspepsia at Rajiv  Gandhi Govt.General Hospitals, Madras Medical College, 
Chennai. 
              On endoscopic examination gastritis and GERD together accounted for 
the majority of the cases. Incidence of malignancy in the present study was 
observed to  be 6.5% (including both gastric and esophageal malignancies). 
                Clinically significant endoscopic findings were observed in 82.5% 
ofpatients with uninvestigated dyspepsia. Most patients presented with a 
complex of three or more dyspeptic symptoms and the symptom profile was not 
predictive of the endoscopic findings. 
                 Prevalence of large number of inflammatory lesions as a result of 
increased acid production,  low incidence of malignancy in the study group 
suggests that the  uninvestigated patients withdyspepsia may be initially 
managed medically with acid  suppressive therapy. 
                Endoscopy may be undertaken in patients with recurrent symptoms or 
in whom drug therapy fails. 
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                                                   SUMMARY  
             A prospective clinico-pathological study was undertaken in RGGGH 
attached to Madras Medical College and Research Institute, Madras to know the 
various endoscopic findings in patients presenting with dyspepsia, prevalence of 
malignancy in these patients. 
             200 patients aged more than 40 years presenting with dyspepsia were 
evaluated. 
The following were the observations: 
1. Highest prevalence of late onset dyspepsia in the age group of 41-50years 
2. Most common presenting complaint was epigastric pain and discomfort 
3. Dyspepsia was more common in males (59%) when compared to females 
4. Most common endoscopic finding was gastritis followed by GERD 
5. Malignancy was diagnosed in 6.5% patients with dyspepsia. 
6. Clinically significant endoscopic findings were observed in 82.5% of 
patientswith uninvestigated dyspepsia. 
 
 
 
 
79 
 
7. Most patients presented with a complex of three or more dyspeptic 
symptomsand the symptom profile was not predictive of the endoscopic 
findings. However, the high prevalence of gastritis (28%), suggests that most 
patients presenting with uninvestigated dyspepsia can be safely managed 
initially with acid suppressive drugs. 
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ANNEXURE-A 
                                 KEY TO MASTER-CHART 
OP.NO - Out patient number. 
Clin- Clinical.. 
HPE- Histopathological Examination. 
EP/A- Epigastric pain/discomfort. 
HB- Heart burn. 
N/V- Nausea/ Vomiting. 
FI- Food intolerance. 
IDG- Indigestion. 
L W/A- Loss of Weight/Appetite. 
PA- Pallor. 
ET- Epigastric tenderness. 
APD- Acid peptic disease 
NS- Normal Study 
Es- Esophagitis. 
Ep- Esophageal polyp. 
HH- Hiatus hernia. 
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GERD- Gastro-esophageal reflux disease. 
BE- Barrett’s esophagus. 
CaE- Carcinoma esophagus. 
Gs- Gastritis. 
GU- Gastric ulcer. 
CaS- Carcinoma Stomach. 
Ds- Duodenitis. 
DU- Duodenal ulcer. 
EG- Esophagogastritis. 
GD- Gastroduodenitis. 
EGD-Esophagogastroduodenitis. 
RE- Reflux esophagitis. 
NSP- No significant pathology. 
M- Male. 
F- Female. 
Y- Yes. 
N- No. 
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Sl.No Name Age Sex  IP No Clinical symptoms signs DIAGNOSIS ENDOSCOPIC 
FINDINGS 
HPE 
EP HB N/V FI ID LOA PA ET 
1 Ravi 45 M 123365 Y Y Y Y Y N N N GERD GS NEG 
2 PERUMAL  47 M 187892 Y Y Y N N N N N APD ES NEG 
 
3 SARATHI 53 M 123698 Y Y Y N N Y Y Y APD GU NEG 
4 KUMAR 58 M 103658 Y N Y Y Y Y Y  APD NS NEG 
5 SARITHA 41 F 100236 N Y Y Y N N N N APD NS NEG 
 
6 VIJAYAL 59 F 136985 N N N Y Y Y Y Y APD HH NEG 
7 FAZIL 65 M  136336 Y Y Y Y Y Y Y Y APD GS NEG 
8 VETRISELVAN 48 M 100013 Y N Y Y Y N N N GERD GU NEG 
9 PUSHPA 40 F 12306 Y Y Y Y Y Y Y Y APD DS NEG 
10 INPHARASAN `49 M 10068 Y N N N Y Y Y Y APD GS NEG 
11 MUNUSAMY 68 M 10981 Y Y N Y N N N N APD DS NEG 
12 VISHWA 40 M 10004 Y Y Y Y Y Y Y Y APD NS NEG 
13 KUPPAN 58 M 90081 Y N N N Y Y Y Y GERD GS NEG 
14 MAYA 42 F 133698 Y N N N N Y Y Y APD NS NEG 
15 VAIGAISELVAN 62 M 97865 N Y Y N N Y Y Y APD DS NEG 
16 PAALPAANDI 76 M 17895 N Y N N Y Y Y Y GERD RE NEG 
17 GANGADURAI 53 M 1436 Y Y Y Y Y Y Y N APD CAS `POS 
18 VENNILA  47 F 19874 Y Y Y N N N N Y APD RE NEG 
19 CHELLADURAI 70 M 99789 `Y Y Y Y N N N N APD NS NEG 
20 UMASELVI 66 F 17568 Y Y N N N N Y Y APD EG NEG 
21 VENKATESH `44 M 1365987 N N Y Y Y Y Y Y APD RE NEG 
22 `VELUSAMY 55 M 123336 Y Y Y Y Y Y Y Y APD GS NEG 
23 BHUVANNAMAL 56 F 45688 Y Y Y N N Y N N APD RE NEG 
24 PRABHAKAR 52 M 8965 Y N Y Y N N Y Y APD RE NEG 
25 VELMURUGAN 41 M 11456 Y Y N N Y Y Y Y APD GS NEG 
 
26 `PRASANNA 46 M 8897 Y Y Y N Y Y Y Y APD EP NEG 
27 CHANDRASEKAR 55 M 9968 Y N N Y Y Y Y N APD GS NEG 
28 PANDIYARAJ 66 M 122566 N N Y Y N N Y Y APD NS NEG 
29 GAYATHRI 46 F 98989 Y Y Y Y Y Y Y N APD CAS POS 
30 MARIYAMMAL 55 F 16556 Y Y N Y N N N Y APD RE NEG 
31 PUSHPAVALLI 69 F 10033 Y Y Y Y N Y N N GERD ES NEG 
32 SUBRAMANIAN 44 M 166678 Y N Y Y Y N N Y APD DU NEG 
33 VADIVELU 68 M 5648 Y Y Y Y N N N Y APD RE NEG 
34 VIJAYAN 56 M 456321 Y N Y N N N N N APD  ES NEG 
35 ANDAAL 66 F 85632 Y Y Y Y Y Y Y Y APD  RE  NEG 
36 RICHARDSON 44 M 122365 N Y Y Y N N Y Y GERD RE NEG 
37 HARIHARAN 43 M 6985 N Y Y Y N N N N APD GS  NEG 
38 RAJESWARI 40 F 9986 Y Y Y Y Y Y Y Y APD  HH NEG 
39 SRINIVASAN 57 M 5555 Y N N N Y Y N N APD GS NEG 
40 RAJENDIRAN 66 M 65987 Y Y Y N N N Y Y APD  ES NEG 
41 KUPPAN 48 M 25464 Y Y Y Y N N Y Y APD RE NEG 
42 ROJA 40 F 124539 N Y Y Y Y N N N GERD NS NEG 
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43 PACHAIAMMAL 56 F 45632 Y Y N Y Y Y Y Y  APD GU NEG 
44 KAVITHA 41 F 444789 N Y Y Y N Y N Y APD GS NEG 
45 SUDHA 49 F 103698 Y N Y N Y N Y N GERD NS   NEG 
46 KIRUBHAKARAN 56 M 3659 Y N N N Y Y Y Y APD RE NEG 
47 GUHAN 56 M 897456 Y Y Y Y Y Y N N APD GU NEG 
48 BHAKIYALAKSHMI 59 F 14586 Y Y Y Y N Y N Y GERD GS NEG 
49 PANNEER SELVAM 48 M 26589 Y Y Y Y Y Y Y N APD ES NEG 
50 FATHIMA BEGAM 56 F 100369 Y N N N N Y Y Y GERD GS NEG 
                
 
 
 
 
 
51 YUVARAJAN 41 M 56987 Y Y Y Y Y N N N APD GS NEG 
52 ABRAHAM 54  M 78965 N Y Y N Y N Y N APD RE NEG 
53 KALYANA BHARATHI 69 M 2365 Y N N Y Y Y Y Y APD GS NEG 
54 ASHOK KUMAR 56 M 444789 Y N Y N Y N N N APD RE NEG 
55 KULANDHAI VEL 56 M 452236 Y Y Y Y Y Y Y Y GERD GU NEG 
56 PURUSHOTHAMAN 44 M 789663 Y Y Y Y Y Y Y Y GERD RE NEG 
57 NALLAMMAL 44 F 111456 Y Y Y Y N N N N GERD NS NEG 
58 KANNAKI 55 F 401145 Y N N Y Y Y Y Y APD CAE POS 
59 MALLIKA 56 F 11145 Y Y N N N N Y Y APD DU NEG 
60 CHITRA 69 F 52365 Y Y Y Y Y Y N Y APD NS NEG 
61 FARZANA 56 F 445669 Y Y Y N Y Y Y N APD GS NEG 
62 ADHIL AHAMED 62 F 445670 Y Y N N N N Y N APD NS  NEG 
63 VIDHYALAKSHMI 44 F 102365 N N N N Y Y Y Y APD HH NEG 
64 VARADHARAJ 55 M 3659 Y Y Y Y Y N Y Y GERD ES NEG 
65 RAMANUJAM 60 M 13699 Y N N N Y  N Y Y APD GS   NEG 
66 MURALIDHARAN 56 M 100365 Y Y N N N N N Y GERD  RE  NEG 
67 BAVANI 66 F  69899 Y Y Y  N N N Y N APD EP NEG 
68 RAJKUMAR 60 M 12132 Y Y N N N N Y Y APD  GS NEG 
69 RAJAMMAL 69 F 100036 Y Y Y Y Y Y Y Y APD ES NEG 
70 MURUGAMMAL 56 F 123004 Y N N N Y Y Y Y GERD HH NEG 
71 SARAVANA KUMAR 63 M 12445 Y Y Y N N N Y Y APD GS NEG 
72 THIYAGARAJAN 46 M 144566 Y N N N Y Y Y Y GERD CAS POS 
73 CHINNSAMY 50 M 23659 Y Y Y Y Y Y Y Y APD DU NEG 
74 KUIYILI 45 F 46236 Y N N N Y Y Y N GERD NS NEG 
75 UMESH KUMAR 66 M 1144569 Y Y Y Y N Y Y N APD GS  NEG 
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76 PERIYASAMY 44 M 1236598 Y Y Y Y Y Y Y N APD EG NEG 
77 ABILASH 54 M 436736 Y N N N N Y Y Y GERD GU NEG 
78 BHASKARAN 70 M 10236 Y Y Y N N N Y Y APD HH NEG 
79 ARUNA CHANDRA 56 F 17789 N Y N Y N Y N Y APD GU NEG 
80 MOHAMED FAZIL 43 M 1036987 Y N Y N Y N Y N APD RE NEG 
81 THOMAS CHERIAN 76 M 104478 Y Y Y N Y Y Y N GERD CAE POS 
82 SRINIVAS REDDY 46 M 11236 Y N N N Y Y N N APD GS NEG 
83 NIRANJANA 56 F 13695 Y N N N N Y Y N GERD NS NEG 
84 BALASUBRAMANIAN 69 M 45609 Y Y Y Y Y N N N APD GS NEG 
85 MANIVEL 65 M 56445 N Y N Y N Y Y Y GERD DU NEG 
86 CHEZIAN 66 M 75569 N Y N Y Y Y N Y GERD RE NEG 
87 ARULMOZHI 44 M 563369 Y Y Y N Y N Y N GERD GS NEG 
88 RANJAN KUMAR 42 M 45778 Y N Y N Y Y N Y GERD GS NEG 
89 BALASUNDARAM 61 M 13025 Y Y Y Y Y Y Y Y GERD ES NEG 
90 DEEPAVALLI 56 F 100236 Y N N N Y Y Y Y APD RE NEG 
91 RAMAKRISHNAN 55 M  47789 Y Y Y N Y Y Y Y GERD GU NEG 
92 MOULEESWARAN 55 M 13036 Y N Y Y N N Y Y GERD EG NEG 
93 MADHAN KUMAR 56 M 13369 Y N N N N N Y Y GERD RE NEG 
94 MUTHAMMA 53 F 10069 Y N N N Y Y Y Y APD NS NEG 
95 DEEPAMMAL 60 F 56933 Y N Y Y Y Y Y Y GERD GS NEG 
96 NARAYANA MURTHY 60 M 456223 Y N Y Y Y Y Y N GERD CAS POS 
97 IRUTHAYA SAMY 56 M 471123 Y Y N N N Y Y Y GERD GS NEG 
98 RAMAKRISHNAN 60 M 13369 Y Y Y N Y Y Y Y APD RE NEG 
100 SUBRAMANIAN 63 M 133023 Y N N Y Y Y Y N GERD GS NEG 
                
 
 
 
101 MARIA 45 F 1236598 Y Y Y Y Y Y Y N APD NS NEG 
102 MALA PAUL 43 F 436736 Y N N N N Y Y Y GERD EG NEG 
103 VIJAYA RAJAN 64 M 10236 Y Y Y N N N Y Y APD EGD NEG 
104 GOVINDHARAJAN 56 M 17789 N Y N Y N Y N Y APD BE NEG 
105 GOVINDHASAMY 45 M 1036987 Y N Y N Y N Y N APD RE NEG 
106 RAJESH 47 M 104478 Y Y Y N Y Y Y N GERD CAS POS 
107 KARTHIK 58 M 11236 Y N N N Y Y N N APD GS NEG 
108 KOWSALYA 53 F 13695 Y N N N N Y Y N GERD RE NEG 
109 VENKATESAN 65 M 45609 Y Y Y Y Y N N N APD GS NEG 
110 SURESH 42 M 56445 N Y N Y N Y Y Y GERD NS NEG 
111 LOGU 75 M 75569 N Y N Y Y Y N Y GERD GS NEG 
112 JAYARANI 56 F 563369 Y Y Y N Y N Y N GERD ES NEG 
113 NAGAPPAN 54 M 45778 Y N Y N Y Y N Y GERD GS NEG 
114 ANBU 56 M 13025 Y Y Y Y Y Y Y Y GERD GD NEG 
115 KASTHURI 54 F 100236 Y N N N Y Y Y Y APD NS NEG 
116 NISHANTHI 46 F 47789 Y Y Y N Y Y Y Y GERD NS NEG 
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117 SENTHILKUMAR 44 M 13036 Y N Y Y N N Y Y GERD EG NEG 
118 GUNASEKAR 44 M 13369 Y N N N N N Y Y GERD NS NEG 
119 IYAPPAN 46 M 10069 Y N N N Y Y Y Y APD NS NEG 
120 MAGESWARI 47 F 56933 Y N Y Y Y Y Y Y GERD GS NEG 
121 PRABHAKAR 42 M 456223 Y N Y Y Y Y Y N GERD CAS POS 
122 RAJALAKSHMI 41 F 471123 Y Y N N N Y Y Y GERD GS NEG 
123 JANAKIRAMAN 40 M 13369 Y Y Y N Y Y Y Y APD NS NEG 
124 MOHAMED RIAZ 41 M 133023 Y N N Y Y Y Y N GERD GS NEG 
125 VETRISELVI 48 F 1236598 Y Y Y Y Y Y Y N APD DS NEG 
1 
 
 
 
 
 
 
126 GUNASEKARAN 45 M 1236598 Y Y Y Y Y Y Y N APD DS NEG 
127 HARINATH 43 M 436736 Y N N N N Y Y Y GERD GS NEG 
128 PONGANESH 64 M 10236 Y Y Y N N N Y Y APD ES NEG 
129 SHANMUGAM 56 M 17789 N Y N Y N Y N Y APD NS NEG 
130 KARTHIKA 45 F 1036987 Y N Y N Y N Y N APD RE NEG 
131 MANIKANDAN 47 M 104478 Y Y Y N Y Y Y N GERD CAS POS 
132 MANIMARAN 58 M 11236 Y N N N Y Y N N APD GS NEG 
133 LALITH 53 M 13695 Y N N N N Y Y N GERD HH NEG 
134 ASHOK 65 M 45609 Y Y Y Y Y N N N APD NS NEG 
135 VISWAKANTH 42 M 56445 N Y N Y N Y Y Y GERD NS NEG 
136 REKHA 75 F 75569 N Y N Y Y Y N Y GERD GS NEG 
137 KAMATCHI 56 F 563369 Y Y Y N Y N Y N GERD GS NEG 
138 VEERAMANI 54 M 45778 Y N Y N Y Y N Y GERD NS NEG 
139 GAYATHRI 56 F 13025 Y Y Y Y Y Y Y Y GERD RE NEG 
140 RAJKUMAR 54 M 100236 Y N N N Y Y Y Y APD EG NEG 
141 MUTHUKRISHNAN 46 M 47789 Y Y Y N Y Y Y Y GERD HH NEG 
142 VIGNESH 44 M 13036 Y N Y Y N N Y Y GERD RE NEG 
143 NAGALAKSHMI 44 F 13369 Y N N N N N Y Y GERD EP NEG 
144 SRIDHAR 46 M 10069 Y N N N Y Y Y Y APD NS NEG 
145 PRAKASH 47 M 56933 Y N Y Y Y Y Y Y GERD GD NEG 
146 RAVI 42 M 456223 Y N Y Y Y Y Y N GERD CAS POS 
147 UMAMAHESWARI 41 F 471123 Y Y N N N Y Y Y GERD NS NEG 
148 JAYAKODI 40 F 56445 N Y N Y N Y Y Y GERD GS NEG 
149 MOHAN 41 M 75569 N Y N Y Y Y N Y GERD NS NEG 
150 RADHA 49 F 563369 Y Y Y N Y N Y N GERD GS NEG 
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151 VIGNESH 57 M 1236598 Y Y Y Y Y Y Y N APD NS NEG 
152 JOSEPH 45 M 436736 Y N N N N Y Y Y GERD GS NEG 
153 PRADEEP KUMAR 52 M 10236 Y Y Y N N N Y Y APD HH NEG 
154 PRATHEEBA 53 F 17789 N Y N Y N Y N Y APD RE NEG 
155 UMA 56 F 1036987 Y N Y N Y N Y N APD RE NEG 
156 UMA 45 F 104478 Y Y Y N Y Y Y N GERD CAS POS 
157 KARTHIKEYAN 67 M 11236 Y N N N Y Y N N APD DU NEG 
158 BHOJAN 42 M 13695 Y N N N N Y Y N GERD NS NEG 
159 THANGARAJAN 55 M 45609 Y Y Y Y Y N N N APD GU NEG 
160 SUGANYA 45 F 56445 N Y N Y N Y Y Y GERD GS NEG 
161 KEERTHANA 42 F 75569 N Y N Y Y Y N Y GERD RE NEG 
162 PRIYA 46 F 563369 Y Y Y N Y N Y N GERD ES NEG 
163 SIVA 71 M 45778 Y N Y N Y Y N Y GERD ES NEG 
164 GANGADHARAN 47 M 13025 Y Y Y Y Y Y Y Y GERD NS NEG 
165 KALPANA 49 F 100236 Y N N N Y Y Y Y APD RE NEG 
166 ABIRAMI 66 F 47789 Y Y Y N Y Y Y Y GERD DS NEG 
167 SEKAR 60 M 13036 Y N Y Y N N Y Y GERD HH NEG 
168 VANATHI 47 F 13369 Y N N N N N Y Y GERD RE NEG 
169 NIBURAJAN 56 F 10069 Y N N N Y Y Y Y APD GU NEG 
170 VIGNESH 41 M 56933 Y N Y Y Y Y Y Y GERD ES NEG 
171 MALLIKA 54 F 456223 Y N Y Y Y Y Y N GERD CAS POS 
172 KALPANA 42 F 471123 Y Y N N N Y Y Y GERD GS NEG 
173 ANANDHAVALLI 46 F 13036 Y N Y Y N N Y Y GERD RE NEG 
174 SENTHAMARAI 54 F 13369 Y N N N N N Y Y GERD NS NEG 
175 AMEERJAAN 64 F 10069 Y N N N Y Y Y Y APD RE NEG 
 
 
 
 
 
 
176 MANIMEGALAI 78 F 1236598 Y Y Y Y Y Y Y N APD GD NEG 
177 KARPAGAM 64 F 436736 Y N N N N Y Y Y GERD GS NEG 
178 SABEER 45 F 10236 Y Y Y N N N Y Y APD RE NEG 
179 INDHUMATHI 58 F 17789 N Y N Y N Y N Y APD GU NEG 
180 DHANDAPANI 68 M 1036987 Y N Y N Y N Y N APD HH NEG 
181 ARJUN 48 M 104478 Y Y Y N Y Y Y N GERD CAS POS 
182 LEENA ROSELIN 66 F 11236 Y N N N Y Y N N APD ES NEG 
183 PALANI 53 M 13695 Y N N N N Y Y N GERD NS NEG 
184 GOPUKUMAR 49 M 45609 Y Y Y Y Y N N N APD GU NEG 
185 RAJI 61 F 56445 N Y N Y N Y Y Y GERD GS NEG 
186 KALAIVANI 55 F 75569 N Y N Y Y Y N Y GERD GS NEG 
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187 MAHABOOBEE 61 F 563369 Y Y Y N Y N Y N GERD DU NEG 
188 THULASI 41 M 45778 Y N Y N Y Y N Y GERD NS NEG 
189 PANDIYARAJ 58 M 13025 Y Y Y Y Y Y Y Y GERD DS NEG 
190 MELVIN 54 M 100236 Y N N N Y Y Y Y APD EG NEG 
191 PRIYA 45 F 47789 Y Y Y N Y Y Y Y GERD GU NEG 
192 CHRIS ALEN PRINCY 43 M 13036 Y N Y Y N N Y Y GERD NS NEG 
193 SHANTHI 45 F 13369 Y N N N N N Y Y GERD RE NEG 
194 HEMAMALINI 55 F 10069 Y N N N Y Y Y Y APD DS NEG 
195 NANDAKUMAR 65 M 56933 Y N Y Y Y Y Y Y GERD GS NEG 
196 BHUVANESHWARI 62 M 456223 Y N Y Y Y Y Y N GERD CAS POS 
197 NANDHINI 49 F 471123 Y Y N N N Y Y Y GERD GS NEG 
198 MANIMEGALAI 60 F 13369 Y Y Y N Y Y Y Y APD GS NEG 
199 KARPAGAM 58 F 133023 Y N N Y Y Y Y N GERD GS NEG 
200 SABEER 70 F 1236598 Y Y Y Y Y Y Y N APD RE NEG 
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ANNEXURE-C                                               
 CLINICAL PROFORMA 
PATIENT DETAILS: 
ON ADMISSION: 
Name : 
Age : 
Sex : 
IP No. : 
Duration of symptoms : 
Co-morbid illness : 
DM : yes / no    IHD / CAD : yes / no 
HT : yes / no 
 
CLINICAL EXAMINATION: 
Pulse : 
BP : 
Anemia : yes / no 
Icterus : yes / no 
Pedal edema : yes / no 
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CVS: 
RS: 
P/A: 
INVESTIGATIONS & INTERVENTION DONE: - 
USG ABD: 
 
CECT ABD: 
 
OGD SCOPY: 
 
BIOPSY TAKEN: (YES/NO)(REPORT IF YES) 
 
 
 
